Justin Meiklem

BIOHARVEST SCIENCES INC. ANNOUNCES SHAREHOLDER APPROVAL OF SHARE CONSOLIDATION

2024 /

VANCOUVER, CANADA, and REHOVOT, ISRAEL, May 29, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) announces that it plans to consolidate (the “Consolidation”) its issued and outstanding common shares (“Common Shares”) on the basis of thirty-five (35) pre-Consolidation Common Shares for every one (1) post-Consolidation Common Share. Pursuant to Section 4.6(8) of […]

BIOHARVEST SCIENCES INC. ANNOUNCES SHAREHOLDER APPROVAL OF SHARE CONSOLIDATION Read More »

img

BioHarvest Sciences to Host Corporate Update Call May 2 at 2:30 p.m. Eastern Time

2024 /

Vancouver, British Columbia and Rehovot, Israel – May 1, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF), a biotechnology company pioneering its patented Botanical Synthesis technology platform, today announced that it will host a corporate update call on Thursday, May 2nd to discuss recently announced milestone achievements, including full year 2023

BioHarvest Sciences to Host Corporate Update Call May 2 at 2:30 p.m. Eastern Time Read More »

BioHarvest

BioHarvest Sciences Reports Fourth Quarter and Full Year 2023 Financial Results

2024, Uncategorized /

Vancouver, British Columbia and Rehovot, Israel – April 30, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF), a biotechnology company pioneering its patented Botanical Synthesis technology platform, today reported its financial and operational results for the fourth quarter and full year ended December 31, 2023. The Company is also announcing an

BioHarvest Sciences Reports Fourth Quarter and Full Year 2023 Financial Results Read More »

BioHarvest Sciences Announces New Campus for Botanical Synthesis CDMO and Expansion of Manufacturing Capacity

2024 /

Vancouver, British Columbia and Rehovot, Israel – April 16, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF), a biotechnology company pioneering its patented Botanical Synthesis technology process, today announced the signing of two agreements: a long term lease agreement  for a new 80,000 square ft. facility  in Yavne, Israel, and an

BioHarvest Sciences Announces New Campus for Botanical Synthesis CDMO and Expansion of Manufacturing Capacity Read More »

BioHarvest Sciences Announces Conversion of Debt Notes

2024 /

Vancouver, British Columbia and Rehovot, Israel – April 3, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF), a biotechnology company pioneering its patented Botanical Synthesis technology platform, today announced an early conversion of convertible debt notes, associated with the convertible debt financing rounds completed on October 2022, November 2022, July

BioHarvest Sciences Announces Conversion of Debt Notes Read More »

BioHarvest Sciences Appoints Anna Tenstam as VP of Business Development, Cosmeceuticals and Injectables

2024 /

Experienced Life Sciences Executive to Support Cosmeceuticals and Injectables Growth for New CDMO Business Unit Vancouver, British Columbia and Rehovot, Israel – March 21, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF), a biotechnology company pioneering its patented Botanical Synthesis technology platform, today announced the appointment of experienced life sciences executive

BioHarvest Sciences Appoints Anna Tenstam as VP of Business Development, Cosmeceuticals and Injectables Read More »